Discrepancies between clinical andautopsy diagnosis and the value of post mortem histology; A meta-analysisand review

Department of Histopathology, Christie Hospital, Manchester, UK.
Histopathology (Impact Factor: 3.45). 01/2006; 47(6):551-9. DOI: 10.1111/j.1365-2559.2005.02243.x
Source: PubMed


The autopsy is in decline, despite the fact that accurate mortality statistics remain essential for public health and health service planning. The falling autopsy rate combined with the Coroners Review and Human Tissue Act have contributed to this decline, and to a falling use of autopsy histology, with potential impact on clinical audit and mortality statistics. At a time when the need for reform and improvement in the death certification process is so prominent, we felt it important to assess the value of the autopsy and autopsy histology. We carried out a meta-analysis of discrepancies between clinical and autopsy diagnoses and the contribution of autopsy histology. There has been little improvement in the overall rate of discrepancies between the 1960s and the present. At least a third of death certificates are likely to be incorrect and 50% of autopsies produce findings unsuspected before death. In addition, the cases which give rise to discrepancies cannot be identified prior to autopsy. Over 20% of clinically unexpected autopsy findings, including 5% of major findings, can be correctly diagnosed only by histological examination. Although the autopsy and particularly autopsy histology are being undermined, they are still the most accurate method of determining the cause of death and auditing accuracy of clinical diagnosis, diagnostic tests and death certification.

Download full-text


Available from: Emyr Wyn Benbow,
  • Source
    • "Multiple research methods, largely retrospective, have been used to examine the epidemiology of diagnostic error (for an extensive overview on incidence, see Graber's article in this issue)10 Commonly used data sources include reports of malpractice claims,6 11 chart reviews of selected diagnoses or hospital admissions2 12 and autopsy reports.13 14 While these studies have given us a general appreciation of the burden of the problem, these estimates of incidence of the problem are far from precise or generalisable. Retrospective methods also introduce hindsight bias in judgments about error determination. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Diagnostic errors remain an underemphasised and understudied area of patient safety research. We briefly summarise the methods that have been used to conduct research on epidemiology, contributing factors and interventions related to diagnostic error and outline directions for future research. Research methods that have studied epidemiology of diagnostic error provide some estimate on diagnostic error rates. However, there appears to be a large variability in the reported rates due to the heterogeneity of definitions and study methods used. Thus, future methods should focus on obtaining more precise estimates in different settings of care. This would lay the foundation for measuring error rates over time to evaluate improvements. Research methods have studied contributing factors for diagnostic error in both naturalistic and experimental settings. Both approaches have revealed important and complementary information. Newer conceptual models from outside healthcare are needed to advance the depth and rigour of analysis of systems and cognitive insights of causes of error. While the literature has suggested many potentially fruitful interventions for reducing diagnostic errors, most have not been systematically evaluated and/or widely implemented in practice. Research is needed to study promising intervention areas such as enhanced patient involvement in diagnosis, improving diagnosis through the use of electronic tools and identification and reduction of specific diagnostic process 'pitfalls' (eg, failure to conduct appropriate diagnostic evaluation of a breast lump after a 'normal' mammogram). The last decade of research on diagnostic error has made promising steps and laid a foundation for more rigorous methods to advance the field.
    BMJ quality & safety 08/2013; 22(Suppl 2). DOI:10.1136/bmjqs-2012-001624 · 3.99 Impact Factor
  • Source
    • "Since persons included in the cohort are new cases in hospitals, these early deaths during follow-up would be persons dying from AIDS who have been diagnosed very late, and these represent only a small percentage of the cohort. Finally, the association between HCV infection and liver-related death could be overestimated if the physician who certified the cause of death knew the HCV status of the subject; those with positive HCV serology would be more likely assigned a liver-related death [42]. While this bias may, indeed, account for some of observed association, it has to be highlighted that we obtained the cause of death for all cohort members from the "
    [Show abstract] [Hide abstract]
    ABSTRACT: We aimed at comparing overall and liver-related mortality rates, observed in HIV positive subjects followed-up in the Cohorts of Spanish Network on HIV/AIDS Research stratified by HCV co-infection status, with the expected mortality of the general population of same age and sex in Spain, for the period 1997 - 2008. We estimated standardized mortality ratio (SMR) and excess mortality, comparing death rates from our cohort (globally and by HCV co-infection) with death rates from the general population standardized by sex in 5year-age bands. Overall, 5914 HIV positive subjects were included, 37.3% of which were co-infected with HCV; 231 deaths occurred, 10.4% of which were liver-related. SMR for all causes mortality for the HIV positive subjects was 5.6 (CI 95% 4.9-6.4), 2.4 (1.9-3.1) for HCV negative subjects and 11.5 (9.9-13.4) for HCV positive ones. Having HCV co-infection and AIDS yielded an SMR of 20.8 (16.5-26.1) and having AIDS and being HCV negative had an SMR of 4.8 (3.5-6.7). SMR for liver-related mortality was 1.8 (0.6-5.7) for HCV negative subjects vs. 22.4 (14.6-34.3) for HCV positive ones. Overall, both mortality rates as SMR and excess mortality rates were higher for injecting drug users (IDUs) than men having sex with men (MSM) and heterosexuals, patients with AIDS, with and without cART and for subjects included between 1997 and 2003. There was an excess of all-cause and liver-related mortality in our cohorts compared with the general population. Furthermore, HCV co-infection in HIV positive patients increased the risk of death for both all causes and liver-related causes.
    Journal of Hepatology 06/2012; 57(4):743-51. DOI:10.1016/j.jhep.2012.06.010 · 11.34 Impact Factor
  • Source
    • "Autopsy studies have revealed important differences between autopsy findings and the clinical diagnosis antemortem (18-25). Such diagnostic disagreement can vary from 10 to 90% depending on the disease and the population involved (5-10,19-21),. Perkins et al. (26-32) showed that among the patients who died in the intensive care unit, 39% of the cases had major missed diagnoses. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Acute respiratory failure is present in 5% of patients with acute myocardial infarction and is responsible for 20% to 30% of the fatal post-acute myocardial infarction. The role of inflammation associated with pulmonary edema as a cause of acute respiratory failure post-acute myocardial infarction remains to be determined. We aimed to describe the demographics, etiologic data and histological pulmonary findings obtained through autopsies of patients who died during the period from 1990 to 2008 due to acute respiratory failure with no diagnosis of acute myocardial infarction during life. This study considers 4,223 autopsies of patients who died of acute respiratory failure that was not preceded by any particular diagnosis while they were alive. The diagnosis of acute myocardial infarction was given in 218 (4.63%) patients. The age, sex and major associated diseases were recorded for each patient. Pulmonary histopathology was categorized as follows: diffuse alveolar damage, pulmonary edema, alveolar hemorrhage and lymphoplasmacytic interstitial pneumonia. The odds ratio of acute myocardial infarction associated with specific histopathology was determined by logistic regression. In total, 147 men were included in the study. The mean age at the time of death was 64 years. Pulmonary histopathology revealed pulmonary edema as well as the presence of diffuse alveolar damage in 72.9% of patients. Bacterial bronchopneumonia was present in 11.9% of patients, systemic arterial hypertension in 10.1% and dilated cardiomyopathy in 6.9%. A multivariate analysis demonstrated a significant positive association between acute myocardial infarction with diffuse alveolar damage and pulmonary edema. For the first time, we demonstrated that in autopsies of patients with acute respiratory failure as the cause of death, 5% were diagnosed with acute myocardial infarction. Pulmonary histology revealed a significant inflammatory response, which has not previously been reported.
    Clinics (São Paulo, Brazil) 03/2012; 67(3):213-7. DOI:10.6061/clinics/2012(03)02 · 1.19 Impact Factor
Show more